New assay selects patients with lung cancer for treatment with immune checkpoint inhibitors

Philadelphia, PA, February 13, 2019 – Immune checkpoint inhibitors, such as the anti-PD-1 antibody pembrolizumab, have become important tools for managing non-small-cell lung cancer (NSCLC). Assessing the level of programmed death ligand 1 (PD-L1) expressed by a tumor can help clinicians determine how the patient should be treated. A report in The Journal of Molecular…

BFU physicists developed a new method to identify antibiotics-resistant bacteria

IMAGE: This is a holder with samples of mycobacterial strains with different antibiotic resistance. view more  Credit: Andrey Zyubin A team of physicists from Immanuel Kant Baltic State University suggested a method to quickly identify single antibiotic-resistant bacteria cells that are the agents of tuberculosis. The new method helps find the bacteria and evaluate their resistance…